176 related articles for article (PubMed ID: 16378833)
21. Characterization of a novel and potent collagen antagonist, caffeic acid phenethyl ester, in human platelets: in vitro and in vivo studies.
Hsiao G; Lee JJ; Lin KH; Shen CH; Fong TH; Chou DS; Sheu JR
Cardiovasc Res; 2007 Sep; 75(4):782-92. PubMed ID: 17560560
[TBL] [Abstract][Full Text] [Related]
22. A monoclonal antibody to platelet type III collagen-binding protein (TIIICBP) binds to blood and vascular cells, and inhibits platelet vessel-wall interactions.
Monnet E; Depraetere H; Legrand C; Deckmyn H; Fauvel-Lafève F
Thromb Haemost; 2001 Aug; 86(2):694-701. PubMed ID: 11522024
[TBL] [Abstract][Full Text] [Related]
23. Systemic sclerosis fibroblasts inhibit in vitro angiogenesis by MMP-12-dependent cleavage of the endothelial cell urokinase receptor.
Serratì S; Cinelli M; Margheri F; Guiducci S; Del Rosso A; Pucci M; Fibbi G; Bazzichi L; Bombardieri S; Matucci-Cerinic M; Del Rosso M
J Pathol; 2006 Oct; 210(2):240-8. PubMed ID: 16917801
[TBL] [Abstract][Full Text] [Related]
24. A familial platelet function disorder associated with abnormal signalling through the glycoprotein VI pathway.
Dunkley S; Arthur JF; Evans S; Gardiner EE; Shen Y; Andrews RK
Br J Haematol; 2007 Jun; 137(6):569-77. PubMed ID: 17539777
[TBL] [Abstract][Full Text] [Related]
25. Platelet collagen receptors, signaling and antagonism: emerging approaches for the prevention of intravascular thrombosis.
Surin WR; Barthwal MK; Dikshit M
Thromb Res; 2008; 122(6):786-803. PubMed ID: 18045662
[TBL] [Abstract][Full Text] [Related]
26. Differential expression of stromal cell-derived factor 1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: Pathogenetic implications.
Cipriani P; Franca Milia A; Liakouli V; Pacini A; Manetti M; Marrelli A; Toscano A; Pingiotti E; Fulminis A; Guiducci S; Perricone R; Kahaleh B; Matucci-Cerinic M; Ibba-Manneschi L; Giacomelli R
Arthritis Rheum; 2006 Sep; 54(9):3022-33. PubMed ID: 16948134
[TBL] [Abstract][Full Text] [Related]
27. A cell model system to study regulation of phosphotidylinositol 3-kinase and protein kinase B activity by cytokines/growth factors produced by type I collagen stimulated immune cells from patients with systemic sclerosis.
Chiang TM; Postlethwaite AE
Biochim Biophys Acta; 2007 Aug; 1770(8):1181-6. PubMed ID: 17524560
[TBL] [Abstract][Full Text] [Related]
28. Density of platelet collagen receptors glycoprotein VI and alpha2beta1 and prior myocardial infarction in human subjects, a pilot study.
Samaha FF; Hibbard C; Sacks J; Chen H; Varello MA; George T; Kahn ML
Med Sci Monit; 2005 May; 11(5):CR224-229. PubMed ID: 15874887
[TBL] [Abstract][Full Text] [Related]
29. [Expression and distribution of type I, III and V collagens in skin lesions from patients with systemic sclerosis].
Liu T; Zhang J
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):748-52. PubMed ID: 19024305
[TBL] [Abstract][Full Text] [Related]
30. Inhibitory effects of endogenous L-arginine analogues on nitric oxide synthesis in platelets: role in platelet hyperaggregability in hypertension.
de Meirelles LR; Mendes-Ribeiro AC; Santoro MM; Mendes MA; da Silva MN; Mann GE; Brunini TM
Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1267-71. PubMed ID: 17973865
[TBL] [Abstract][Full Text] [Related]
31. Hemorheologic profile in systemic sclerosis: role of NOS3 -786T > C and 894G >T polymorphisms in modulating both the hemorheologic parameters and the susceptibility to the disease.
Fatini C; Mannini L; Sticchi E; Rogai V; Guiducci S; Conforti ML; Cinelli M; Pignone AM; Bolli P; Abbate R; Cerinic MM
Arthritis Rheum; 2006 Jul; 54(7):2263-70. PubMed ID: 16802365
[TBL] [Abstract][Full Text] [Related]
32. Allicin and disulfiram enhance platelet integrin alphaIIbbeta3-fibrinogen binding.
Manaster Y; Shenkman B; Rosenberg N; Savion N
Thromb Res; 2009 Sep; 124(4):477-82. PubMed ID: 19632706
[TBL] [Abstract][Full Text] [Related]
33. Isolation of a type IV collagen binding protein from human platelets.
Menon RP; Sudhakaran PR
Indian J Biochem Biophys; 1991; 28(5-6):531-5. PubMed ID: 1667397
[TBL] [Abstract][Full Text] [Related]
34. A functional proteomic method for the enrichment of peripheral membrane proteins reveals the collagen binding protein Hsp47 is exposed on the surface of activated human platelets.
Kaiser WJ; Holbrook LM; Tucker KL; Stanley RG; Gibbins JM
J Proteome Res; 2009 Jun; 8(6):2903-14. PubMed ID: 19341245
[TBL] [Abstract][Full Text] [Related]
35. Monocyte chemoattractant protein 1 released from glycosaminoglycans mediates its profibrotic effects in systemic sclerosis via the release of interleukin-4 from T cells.
Distler JH; Jüngel A; Caretto D; Schulze-Horsel U; Kowal-Bielecka O; Gay RE; Michel BA; Müller-Ladner U; Kalden JR; Gay S; Distler O
Arthritis Rheum; 2006 Jan; 54(1):214-25. PubMed ID: 16385517
[TBL] [Abstract][Full Text] [Related]
36. Circulating platelets as a source of the damage-associated molecular pattern HMGB1 in patients with systemic sclerosis.
Maugeri N; Franchini S; Campana L; Baldini M; Ramirez GA; Sabbadini MG; Rovere-Querini P; Manfredi AA
Autoimmunity; 2012 Dec; 45(8):584-7. PubMed ID: 22928592
[TBL] [Abstract][Full Text] [Related]
37. Affinity modulation in platelet alpha 2 beta 1 following ligand binding.
Gofer-Dadosh N; Klepfish A; Schmilowitz H; Shaklai M; Lahav J
Biochem Biophys Res Commun; 1997 Mar; 232(3):724-7. PubMed ID: 9126343
[TBL] [Abstract][Full Text] [Related]
38. [Glycoprotein VI--collagen receptor activating blood platelets].
Kralisz U
Postepy Biochem; 2003; 49(1):26-38. PubMed ID: 14518395
[No Abstract] [Full Text] [Related]
39. Elevated serum BAFF levels in patients with systemic sclerosis: enhanced BAFF signaling in systemic sclerosis B lymphocytes.
Matsushita T; Hasegawa M; Yanaba K; Kodera M; Takehara K; Sato S
Arthritis Rheum; 2006 Jan; 54(1):192-201. PubMed ID: 16385515
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of angiogenesis by platelets in systemic sclerosis patients.
Hirigoyen D; Burgos PI; Mezzano V; Duran J; Barrientos M; Saez CG; Panes O; Mezzano D; Iruretagoyena M
Arthritis Res Ther; 2015 Nov; 17():332. PubMed ID: 26584613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
